TNXP: Tonix Pharmaceuticals Holding Corp.
Performance
TNXP -73.59%
Watchlist
Select an item
Summary
TNXP at a glance
TNXP returned -73.59% over the past year and -89.43% a year over five years. Its worst drop in that year was -77.43%, smaller than 2% of stocks on Redstone, and its Sharpe ratio of -1.56 beats 0% of stocks on Redstone. It pays no dividends.
Current Drawdown
-77.43%
Rolling Volatility
65.07%
Actions
Metrics
Risk Indicators
Alpha-127.97%
Beta1.66x
Sharpe-1.56
Sortino-2.15
Omega0.77
Calmar-0.95
Martin-2.94
Profile
About TNXP
Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $77M
- Listed
- Feb 2009
- Employees
- 142
- Headquarters
- Berkeley Heights, NJ
- Website
- tonixpharma.com
Comparisons